Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Breast Cancer |
Free Subscription
2 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
Editorial Comment: Breast Cryoablation-A Promising Technology to Nonsurgically
Treat Small Low-Risk Breast Cancer.
AJR Am J Roentgenol. 2024 May 1. doi: 10.2214/AJR.24.31346.
PubMed
MRI-Guided Breast Cryoablation With the Patient in Prone Position.
AJR Am J Roentgenol. 2024 Feb 14. doi: 10.2214/AJR.23.30754.
PubMed
Utilizing PTEN immunohistochemistry as a screening test for Cowden syndrome.
Am J Clin Pathol. 2024;161:490-500.
PubMed
Abstract available
Cytologic analysis of metaplastic breast carcinoma: Review of 66 cases diagnosed
at the Institut Curie.
Am J Clin Pathol. 2024;161:430-435.
PubMed
Abstract available
Event-free survival by residual cancer burden with pembrolizumab in early-stage
TNBC: exploratory analysis from KEYNOTE-522.
Ann Oncol. 2024;35:429-436.
PubMed
Abstract available
Survival After Contralateral Axillary Metastasis in Breast Cancer.
Ann Surg Oncol. 2024 May 2. doi: 10.1245/s10434-024-15370.
PubMed
Abstract available
ASO Author Reflections: Increasing Time of Diagnosis to Breast Cancer Surgery.
Ann Surg Oncol. 2024 Apr 29. doi: 10.1245/s10434-024-15295.
PubMed
Contrast-enhanced Ultrasound Using Intradermal Microbubble Sulfur Hexafluoride in
Non-invasive Axillary Staging in Breast Cancer: Are we Missing a Chance?
Anticancer Res. 2024;44:2021-2030.
PubMed
Abstract available
Twenty-five Years Overall Survival Prognostic Value of the Lymph Node Ratio in De
Novo Metastatic Breast Cancer.
Anticancer Res. 2024;44:1995-2002.
PubMed
Abstract available
The Impact of Neoadjuvant Chemotherapy on Axillary Surgical Management of
Patients With Breast Cancer and Positive Axillary Lymph Nodes.
Anticancer Res. 2024;44:2047-2053.
PubMed
Abstract available
Breast Relapse of Pediatric B-Cell Acute Lymphoblastic Leukemia After CAR-T
Therapy Detected by (18)F-FDG PET/CT.
Anticancer Res. 2024;44:2243-2245.
PubMed
Abstract available
Inactivation of the Tumor Suppressor CYLD Sensitizes Mice to Breast Cancer
Development.
Anticancer Res. 2024;44:1885-1894.
PubMed
Abstract available
The use of longitudinal CT-based radiomics and clinicopathological features
predicts the pathological complete response of metastasized axillary lymph nodes
in breast cancer.
BMC Cancer. 2024;24:549.
PubMed
Abstract available
Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct
mechanisms in triple-negative and luminal breast cancer.
BMC Cancer. 2024;24:532.
PubMed
Abstract available
Adverse effects of tamoxifen treatment on bone mineral density in premenopausal
patients with breast cancer: a systematic review and meta-analysis.
Breast Cancer. 2024 Apr 27. doi: 10.1007/s12282-024-01586.
PubMed
Abstract available
Percutaneous ultrasound-guided cryoablation for early-stage primary breast
cancer: a follow-up study in Japan.
Breast Cancer. 2024 Apr 27. doi: 10.1007/s12282-024-01584.
PubMed
Abstract available
Real-world data of HER2-negative early breast cancer patients treated with
anthracycline and/or taxane regimens in Japan.
Breast Cancer. 2024 Apr 29. doi: 10.1007/s12282-024-01572.
PubMed
Abstract available
Breast Cancer (Dove Med Press)
Expression and Significance of LINC02418 in Breast Cancer.
Breast Cancer (Dove Med Press). 2024;16:233-243.
PubMed
Abstract available
Breast density knowledge and willingness to delay treatment for pre-operative
breast cancer imaging among women with a personal history of breast cancer.
Breast Cancer Res. 2024;26:73.
PubMed
Abstract available
Correction: Five-year survival prognosis of young, middle-aged, and elderly adult
female invasive breast cancer patients by clinical and lifestyle characteristics.
Breast Cancer Res Treat. 2024 May 2. doi: 10.1007/s10549-024-07335.
PubMed
Circulating microRNAs and therapy-associated cardiac events in HER2-positive
breast cancer patients: an exploratory analysis from NeoALTTO.
Breast Cancer Res Treat. 2024 Apr 30. doi: 10.1007/s10549-024-07299.
PubMed
Abstract available
Ten-year trend analysis of breast cancer, oncoplastic, and reconstructive breast
surgery in a single institution (2010-2019), what has not changed?
Breast Cancer Res Treat. 2024 Apr 30. doi: 10.1007/s10549-024-07294.
PubMed
Abstract available
Risk of first recurrence after treatment in a population-based cohort of young
women with breast cancer.
Breast Cancer Res Treat. 2024 Apr 30. doi: 10.1007/s10549-024-07338.
PubMed
Abstract available
Clinico-pathologic factors and survival of patients with breast cancer diagnosed
with de novo brain metastasis: a national cancer database analysis.
Breast Cancer Res Treat. 2024 Apr 29. doi: 10.1007/s10549-024-07321.
PubMed
Abstract available
Neoadjuvant chemotherapy for triple-negative and Her2 +ve breast cancer: striving
for the standard of care.
Breast Cancer Res Treat. 2024 Apr 27. doi: 10.1007/s10549-024-07282.
PubMed
Abstract available
Use of ultrasound and MRI to stage the axilla for breast cancer before and after
neoadjuvant chemotherapy prior to targeted sentinel lymphadenectomy.
Breast Cancer Res Treat. 2024 May 3. doi: 10.1007/s10549-024-07332.
PubMed
Abstract available
Randomized placebo-controlled, double-blind clinical trial of nanoemulsion
curcumin in women with aromatase inhibitor-induced arthropathy: an Alliance/NCORP
pilot trial.
Breast Cancer Res Treat. 2024;205:61-73.
PubMed
Abstract available
Comparisons of assessment pathways after abnormal mammography screening in
Denmark, Norway, and Spain.
Breast Cancer Res Treat. 2024;205:135-145.
PubMed
Abstract available
Information needs in breast reconstruction after mastectomy: a qualitative
analysis of free-text responses from 2077 women.
Breast Cancer Res Treat. 2024;205:147-157.
PubMed
Abstract available
MRI-visualized T2 hyperintense breast lesions: identifying clinical and imaging
factors linked to malignant biopsy outcomes.
Breast Cancer Res Treat. 2024;205:159-168.
PubMed
Abstract available
Gene polymorphisms of TACR1 serve as the potential pharmacogenetic predictors of
response to the neurokinin-1 receptor antagonist-based antiemetic regimens: a
candidate-gene association study in breast cancer patients.
Cancer Chemother Pharmacol. 2024 Apr 27. doi: 10.1007/s00280-024-04661.
PubMed
Abstract available
Cancer Epidemiol Biomarkers Prev
Diffsig: Associating Risk Factors with Mutational Signatures.
Cancer Epidemiol Biomarkers Prev. 2024;33:721-730.
PubMed
Abstract available
Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by
Geography and Socioeconomic Status.
Cancer Epidemiol Biomarkers Prev. 2024;33:654-661.
PubMed
Abstract available
Breast Cancer Screening: Can We Justify Deescalation?
Cancer Epidemiol Biomarkers Prev. 2024;33:638-640.
PubMed
Abstract available
Addressing Social Determinants in the Era of Precision Medicine in Breast Cancer:
Is It Sufficient to Reduce Disparities?
Cancer Epidemiol Biomarkers Prev. 2024;33:635-637.
PubMed
Abstract available
circLIFR-007 reduces liver metastasis via promoting hnRNPA1 nuclear export and
YAP phosphorylation in breast cancer.
Cancer Lett. 2024;592:216907.
PubMed
Abstract available
Inhibition of MFN1 restores tamoxifen-induced apoptosis in resistant cells by
disrupting aberrant mitochondrial fusion dynamics.
Cancer Lett. 2024;590:216847.
PubMed
Abstract available
A glycolytic metabolite bypasses "two-hit" tumor suppression by BRCA2.
Cell. 2024;187:2269-2287.
PubMed
Abstract available
Survival Outcomes in Thyroid Cancer Patients with Co-Occurring Breast Cancer:
Evidence of Mortality Risk Attenuation.
Clin Breast Cancer. 2024 Apr 6:S1526-8209(24)00102.
PubMed
Abstract available
Screening Mammography for Males With Elevated Breast Cancer Risk, Mutation
Carriers, and Gynecomastia.
Clin Breast Cancer. 2024 Apr 4:S1526-8209(24)00100.
PubMed
Abstract available
The Efficiency and Toxicity Of Anlotinib in Combination With Docetaxel Followed
by Epirubicin and Cyclophosphamide Regimen as Neoadjuvant Treatment in IIB to
IIIA Triple Negative Breast Cancer: A Single-Arm, Multicenter, Open-Label, Phase
II Study.
Clin Breast Cancer. 2024 Mar 8:S1526-8209(24)00028.
PubMed
Abstract available
Impact of radiation therapy for breast cancer with involved surgical margin after
immediate breast reconstruction: A multi-institutional observational study.
Eur J Surg Oncol. 2024;50:108360.
PubMed
Abstract available
Quantitative assessment of background parenchymal enhancement is associated with
lifetime breast cancer risk in screening MRI.
Eur Radiol. 2024 Apr 29. doi: 10.1007/s00330-024-10758.
PubMed
Abstract available
Extrachromosomal circular DNA landscape of breast cancer with lymph node
metastasis.
Int J Cancer. 2024 May 1. doi: 10.1002/ijc.34985.
PubMed
Abstract available
Second primary cancer risks according to race and ethnicity among U.S. breast
cancer survivors.
Int J Cancer. 2024 Apr 29. doi: 10.1002/ijc.34971.
PubMed
Abstract available
Longitudinal assessment of tumor-infiltrating lymphocytes in primary breast
cancer following neoadjuvant radiotherapy.
Int J Radiat Oncol Biol Phys. 2024 Apr 26:S0360-3016(24)00566.
PubMed
Abstract available
YAP/TAZ-mediated regulation of laminin 332 is enabled by beta4 integrin repression
of ZEB1 to promote ferroptosis resistance.
J Biol Chem. 2024;300:107202.
PubMed
Abstract available
Erratum: Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone
Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk
Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim
Analysis, Including 5-Yea
J Clin Oncol. 2024 Apr 30:JCO2400711. doi: 10.1200/JCO.24.00711.
PubMed
Survivorship and breast cancer: Navigating the continuum of care.
J Surg Oncol. 2024 May 1. doi: 10.1002/jso.27671.
PubMed
Screening for Breast Cancer.
JAMA. 2024 Apr 30. doi: 10.1001/jama.2024.5535.
PubMed
Toward More Equitable Breast Cancer Outcomes.
JAMA. 2024 Apr 30. doi: 10.1001/jama.2024.6052.
PubMed
Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502
Randomized Trial.
JAMA. 2024 Apr 29:e244840. doi: 10.1001/jama.2024.4840.
PubMed
Abstract available
Screening for Breast Cancer: Evidence Report and Systematic Review for the US
Preventive Services Task Force.
JAMA. 2024 Apr 30. doi: 10.1001/jama.2023.25844.
PubMed
Abstract available
Screening for Breast Cancer: US Preventive Services Task Force Recommendation
Statement.
JAMA. 2024 Apr 30. doi: 10.1001/jama.2024.5534.
PubMed
Abstract available
Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A
Decision Analysis for the US Preventive Services Task Force.
JAMA. 2024 Apr 30. doi: 10.1001/jama.2023.24766.
PubMed
Abstract available
Young Patients Without Genetic Risk Have Low Chance of Second Breast Cancer.
JAMA. 2024 May 3. doi: 10.1001/jama.2024.6734.
PubMed
Post-radiation angiosarcoma of the breast in a patient with a history of invasive
ductal carcinoma.
Lancet. 2024;403:1681-1682.
PubMed
Trastuzumab deruxtecan versus treatment of physician's choice in patients with
HER2-positive metastatic breast cancer (DESTINY-Breast02): patient-reported
outcomes from a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol. 2024;25:614-625.
PubMed
Abstract available
Trastuzumab: dreams, desperation and hope.
Nat Rev Cancer. 2024;24:287-288.
PubMed
Impact of dose reductions on adjuvant abemaciclib efficacy for patients with
high-risk early breast cancer: analyses from the monarchE study.
NPJ Breast Cancer. 2024;10:34.
PubMed
Abstract available
A novel bioinformatic approach reveals cooperation between Cancer/Testis genes in
basal-like breast tumors.
Oncogene. 2024;43:1369-1385.
PubMed
Abstract available
Correction: Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways
suppresses breast cancer stem cells, tumor growth, and metastasis.
Oncogene. 2024 Apr 27. doi: 10.1038/s41388-024-03046.
PubMed
Suppression of lysosome metabolism-meditated GARP/TGF-beta1 complexes specifically
depletes regulatory T cells to inhibit breast cancer metastasis.
Oncogene. 2024 May 2. doi: 10.1038/s41388-024-03043.
PubMed
Abstract available
Machine-learning and mechanistic modeling of metastatic breast cancer after
neoadjuvant treatment.
PLoS Comput Biol. 2024;20:e1012088.
PubMed
Abstract available
Early therapy evaluation of intra-arterial trastuzumab injection in a human
breast cancer xenograft model using multiparametric MR imaging.
PLoS One. 2024;19:e0300171.
PubMed
Abstract available
Association of the bitter taste genes TAS2R38 and CA6 and breast cancer risk; a
case-control study of Polish women in Poland and Polish immigrants in USA.
PLoS One. 2024;19:e0300061.
PubMed
Abstract available
BI-RADS Category Assignments by GPT-3.5, GPT-4, and Google Bard: A Multilanguage
Study.
Radiology. 2024;311:e232133.
PubMed
Abstract available
Addition of Contrast-enhanced Mammography to Tomosynthesis for Breast Cancer
Detection in Women with a Personal History of Breast Cancer: Prospective TOCEM
Trial Interim Analysis.
Radiology. 2024;311:e231991.
PubMed
Abstract available
Thank you for your interest in scientific medicine.